Risk of NTD among live births exposed to maternal RX opioids during early pregnancy
Ended Awarded Last action
- Contract number
- HHSF22301002T
- Awardee
-
Harvard Pilgrim Health Care, Inc. UEI NZVVQ8GNVX65
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $3,783,345
Award facts
- Contract value 100% obligated
- $3,783,344.87 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Wellesley Hills, Wellesley, MA 02481, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $88,494 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $39,491 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,655,360 |
About this award
This is a federal contract award to Harvard Pilgrim Health Care Inc. Office of Sponsored Programs Division, a non-profit healthcare organization, by the Food and Drug Administration (FDA). The $3,783,344.87 contract is for a delivery order under the FDA's Scientific Pharmacoepidemiologic Research Program, with the purpose of studying the risk of neural tube defects (NTDs) among live births exposed to maternal prescription opioid use during early pregnancy. The contract does not have a set-aside designation. Harvard Pilgrim has extensive experience conducting large-scale observational studies and clinical trials in partnership with federal health agencies, particularly within the Department of Health and Human Services, and holds several indefinite delivery/indefinite quantity (IDIQ) contracts to provide ongoing data analytics, pharmacoepidemiology, and public health research services to key federal health agencies such as the FDA and Centers for Disease Control and Prevention (CDC).
Quick answers
Who was awarded contract HHSF22301002T?
HHSF22301002T was awarded to Harvard Pilgrim Health Care, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 23, 2016.
How much is contract HHSF22301002T worth?
The government has obligated $3,783,345 on HHSF22301002T.
Is contract HHSF22301002T an order under another contract?
Yes. HHSF22301002T is a delivery order under HHSF223201400042I, an indefinite delivery contract, on FDA Scientific Pharmacoepidemiologic Research Program.
Was contract HHSF22301002T competed?
The extent of competition for HHSF22301002T was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award